Breaking News

iBio Inks First Fill-Finish Services Agreement

To provide cGMP sterile fill-finish for the customer’s investigational therapy for late-stage clinical trial

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

iBio, Inc. has initiated its new cGMP sterile fill-finish services operation with the signing of a supply agreement with a clinical-stage biopharmaceutical company developing gene and cell therapies.  Earlier in June, iBio introduced its cGMP sterile fill-finish capabilities for pharmaceutical products, including monoclonal antibodies, viral vectors and other biologics at its 135,000 square foot CDMO facility located in Bryan, TX. The company will initially focus on clients with preclinical a...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters